Telix Supports Molecular Imaging Summer Program at MSKCC
Telix Pharmaceuticals Ltd is pleased to announce our support of the Molecular Imaging Summer Program at…
Read moreNews & Views
Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging
Telix Pharmaceuticals Limited is pleased to announce that the FDA has approved the ZIRCON study for American…
Read more
Robyn Jackson, MBA, CNMT Joins Telix Pharmaceuticals US
News,
With over 15 years of hands-on experience in Diagnostic Imaging and Sales, Robyn will be solidifying our presence in the Western US. Robyn has an extensive background in Diagnostic Imaging…
Read more
Anthony Zinno, MBA Joins Telix Pharmaceuticals US
News,
With more than 26 years of operations experience in the healthcare and life sciences field, Tony will be leading the sales organization as Vice President of Commercial Operations. Tony’s success…
Read more
NDA Clinical Briefing Package Submitted to the US FDA
Telix Pharmaceuticals announces that it has submitted a complete clinical briefing package to the US FDA for its first product…
Read more
ZIRCON Phase 3 IND Submitted to the US FDA
Telix Pharmaceuticals Limited announces that it has submitted a Phase 3 IND application to the FDA for…
Read more
TLX101 for Brain Cancer IPAX-1 Study Update
Telix Pharmaceuticals has released an update on the progress of its TLX101 product in the treatment of glioblastoma…
Read more
University of Melbourne collaboration with Telix receives Cancer Australia research grant
News,
Telix Pharmaceuticals announces University of Melbourne collaboration with Telix receives Cancer Australia research…
Read more
Telix Pharmaceuticals and ATONCO Partner for Bladder Cancer
Telix Pharmaceuticals Limited and French company ATONCO S.A.S are pleased to announce they have entered into a Licence and Development Agreement that will enable ATONCO to investigate the use of Telix’s…
Read more
Webcast of CEO’s presentation to Jefferies 2019 London Healthcare Conference
Telix Pharmaceuticals Limited is pleased to announce that Group CEO, Dr. Christian Behrenbruch, presented at Jefferies 2019 London Healthcare Conference….
Read more